Response from Robert Klein to Lee-Halpern Petition
By Robertk Klein
| 03. 18. 2005
Dear Mr. Halpern and Dr. Lee,
The petition that you filed with the California Institute for Regenerative Medicine on Wednesday, February 16, 2005 raises very important issues, which merit careful consideration by the full body of the Independent Citizens' Oversight Committee (ICOC), the governing board of the institute, in public meetings. The ICOC intends, as we have previously stated in public hearings, to invite the public to participate in open discussions of each of these items. In addition, we reiterate that no research grants will be awarded until appropriate excellent standards are in place, based upon NIH standards where applicable and/or National Academy of Sciences standards (or similar highly respected and proven standards) when those standards cover areas not fully addressed by the NIH standards. All of these decisions are subject to ICOC study, review, and approval.
As an interim solution, while we work to schedule public discussion of the meaningful questions that you raise, the ICOC has deemed it most appropriate to delegate authority to me to work with counsel to respond to your petition on its merits. Our...
Related Articles
By Brittany Luse, Corey Antonio Rose, Neena Pathak, NPR | 02.27.2026
Who gets to be "hot" in America? And, at what cost?
Some young men are pushing beauty boundaries with guidance from an online trend that's been making headlines: looksmaxxing. Looksmaxxing celebrates intense fitness & skincare routines, extreme body modification, and...
By Kiana Jackson and Shannon Stubblefield, New Disabled South | 02.09.2026
"MC0_8230" via Wikimedia Commons licensed under CC by 2.0
This report documents a deliberate assault on disabled people in the United States. Not an accident. Not a series of bureaucratic missteps. An assault that has been coordinated across agencies...
By David Jensen, California Stem Cell Report | 02.10.2026
Touchy issues involving accusations that California’s $12 billion gene and stem cell research agency is pushing aside “good science” in favor of new priorities and preferences will be aired again in late March at a public meeting in Sacramento.
The...
By Ava Kofman, The New Yorker | 02.09.2026
1. The Surrogates
In the delicate jargon of the fertility industry, a woman who carries a child for someone else is said to be going on a “journey.” Kayla Elliott began hers in February, 2024, not long after she posted...